SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 38 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $9,153,200 | +9.8% | 4,900,000 | -2.0% | 0.00% | – |
Q3 2022 | $8,333,000 | +23.8% | 5,000,000 | -7.0% | 0.00% | – |
Q2 2022 | $6,732,000 | -26.1% | 5,375,000 | -22.7% | 0.00% | – |
Q1 2022 | $9,113,000 | +59.5% | 6,950,000 | +78.2% | 0.00% | – |
Q4 2021 | $5,712,000 | +38.7% | 3,900,000 | +24.8% | 0.00% | – |
Q2 2021 | $4,119,000 | -5.9% | 3,125,000 | -6.7% | 0.00% | – |
Q1 2021 | $4,376,000 | -37.4% | 3,350,000 | +17.5% | 0.00% | – |
Q4 2020 | $6,988,000 | +43.4% | 2,850,000 | +21.3% | 0.00% | – |
Q3 2020 | $4,873,000 | -9.6% | 2,350,000 | 0.0% | 0.00% | – |
Q2 2020 | $5,393,000 | +92.1% | 2,350,000 | +27.0% | 0.00% | – |
Q1 2020 | $2,808,000 | -0.4% | 1,850,000 | +27.6% | 0.00% | – |
Q4 2019 | $2,820,000 | +47.2% | 1,450,000 | 0.0% | 0.00% | – |
Q3 2019 | $1,916,000 | -40.6% | 1,450,000 | 0.0% | 0.00% | – |
Q2 2019 | $3,228,000 | +23.4% | 1,450,000 | 0.0% | 0.00% | – |
Q1 2019 | $2,616,000 | – | 1,450,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DeepCurrents Investment Group LLC | 53,865,000 | $101,127,280 | 3.93% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 88,657,000 | $165,397,613 | 3.42% |
Boussard & Gavaudan Investment Management LLP | 11,898 | $21,871,538 | 2.42% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 38,394,000 | $71,834,226 | 1.71% |
WOLVERINE ASSET MANAGEMENT LLC | 79,876,000 | $149,367,384 | 1.55% |
CSS LLC/IL | 4,747,000 | $8,868,606 | 0.50% |
Opti Capital Management, LP | 3,000,000 | $5,611,938 | 0.48% |
Verition Fund Management LLC | 16,459,000 | $30,786,560 | 0.48% |
Aequim Alternative Investments LP | 5,000,000 | $9,352,500 | 0.25% |
MIZUHO SECURITIES USA LLC | 1,097,000 | $2,047,616 | 0.19% |